Found 5 matching trials
Study of the Safety of PIM447 in Combination With Ruxolitinib (INC424) and LEE011 in Patients With Myelofibrosis
PHASE1This is a phase Ib study with the primary purpose is to estimate the MTD an...
Location
Novartis Investigative Site
Dose Escalation Study of LGH447 in Japanese Patients With Relapsed and/or Refractory Hematologic Malignancies
PHASE1This is a multi-center, open-label, dose escalation, Phase 1 study of oral ...
Location
Novartis Investigative Site
A Study of Oral LGH447 in Patients With Relapsed and/or Refractory Multiple Myeloma
PHASE1The primary purpose of this dose escalation study is to estimate the maximu...
Location
Novartis Investigative Site
Study of the Safety and Effectiveness of LGH447 and BYL719 in Patients With Relapsed and Refractory Multiple Myeloma
PHASE1This is a Phase Ib/II study with the primary purpose of the Phase Ib part b...
Location
University of Texas/MD Anderson Cancer Center Dept.ofMDAndersonCancerCtr(SC)
A Safety and Efficacy Study of LGH447 in Patients With Acute Myeloid Leukemia (AML) or High Risk Myelodysplastic Syndrome (MDS)
PHASE1This study will assess the safety and preliminary efficacy of escalating do...
Location
Novartis Investigative Site